Blast Crisis (Blast Phase) Summary

Networked: 1213 relevant articles (110 outcomes, 116 trials/studies) for this Disease

Key Drugs and Agents for Blast Crisis

1. imatinib (Gleevec) : 39 outcomes 28 studies in 285 results : FDA 3
   
2. dasatinib (BMS 354825) : 8 outcomes 7 studies in 47 results : FDA 2
   
3. Cytarabine (Cytosar-U) : 7 outcomes 12 studies in 61 results : FDA 13 Generic
   
4. Interferon-alpha (Interferon Alfa) : 5 outcomes 2 studies in 16 results : FDA 2
   
5. Hydroxyurea (Hydrea) : 5 outcomes 1 study in 26 results : FDA 6 Generic
   
6. Protein-Tyrosine Kinases (Tyrosine Kinase) : 5 outcomes in 53 results : IBA
   
7. Vincristine (Oncovin) : 5 outcomes in 31 results : FDA 17 Generic
   
8. Busulfan (Busulfex) : 4 outcomes 2 studies in 20 results : FDA 2
   
9. Prednisone (Sone) : 4 outcomes 2 studies in 14 results : FDA 119 Generic
   
10. 4- methyl- N- (3- (4- methylimidazol- 1- yl)- 5- (trifluoromethyl)phenyl)- 3- ((4- pyridin- 3- ylpyrimidin- 2- yl)amino)benzamide (nilotinib) : 3 outcomes 4 studies in 23 results : FDA 1
    

Diseases Related to Blast Crisis

1. BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
2. Leukemia
3. Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
4. Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
5. Philadelphia Chromosome

Key Therapies for Blast Crisis

1. Drug Therapy (Chemotherapy) : 16 outcomes 2 studies in 79 results
   
2. Transplants (Transplant) : 5 outcomes 2 studies in 38 results
   
3. Transplantation (Transplant Recipients) : 4 outcomes 1 study in 34 results
   
4. Bone Marrow Transplantation (Transplantation, Bone Marrow) : 4 outcomes 1 study in 30 results
   
5. Stem Cell Transplantation : 3 outcomes in 22 results